Loxapine

Product NDC: 0591-0372
Requested package NDC: 0591-0372-00
11-digit product format: 005910372
Labeler code: 0591
Product ID: 0591-0372_cae2db34-6be2-45cf-b9b5-9b929650eb4f
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Loxapine
Dosage form: CAPSULE
Route: ORAL
Labeler: Actavis Pharma, Inc.
Application: ANDA072062
Marketing category: ANDA
Marketing start: 1988-06-15
Substance: LOXAPINE SUCCINATE
Active strength: 50 mg/1
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
unfinished package	package	0591-0372	0591-0372-00	UNFINISHED	Active or certified unfinished drug listing		2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 21 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 21:27 UTC · source 2025-12-05	`a6255e0c9aa5…`	`a0211a219f2e…`
2025-08-26 23:59 UTC · source 2025-08-26	`1d862106b807…`	`00c93037cd84…`
2025-05-15 14:59 UTC · source 2025-05-14	`390b4c401c3f…`	`2c692c2daee3…`
2025-04-01 07:37 UTC · source 2025-03-31	`e30019b0c005…`	`a3f0b14938b7…`
2025-03-01 13:19 UTC · source 2025-02-28	`bbbc9f937eca…`	`946b9c97cf81…`
2025-02-27 05:24 UTC · source 2025-02-26	`f268b84574a6…`	`26285f5ac5df…`
2025-02-01 13:13 UTC · source 2025-01-31	`f764e8902f78…`	`92046438deef…`
2025-01-20 13:05 UTC · source 2025-01-17	`68b1e3bced9e…`	`98a755eb8bc6…`
2024-11-29 20:42 UTC · source 2024-11-29	`05c55d027831…`	`ca05dca9dc4c…`
2024-11-09 02:36 UTC · source 2024-11-08	`48b4f40e6753…`	`c7c7a00d2afa…`
2024-10-09 02:27 UTC · source 2024-10-08	`27f29a85d7e4…`	`1372111e901f…`
2024-07-10 04:00 UTC · source 2024-07-09	`8d62ce987f31…`	`9fe9ef23e30d…`
2024-05-28 21:11 UTC · source 2024-05-28	`d1e113ab4d42…`	`063ee3eb0a1d…`
2024-05-15 03:51 UTC · source 2024-05-14	`50b4072663b7…`	`eae3003ed65e…`
2022-04-09 23:13 UTC · source 2022-04-08	`906f6e251498…`	`bf70b80e44f0…`
2021-12-27 23:28 UTC · source 2021-12-27	`6db9cb8d1e19…`	`3449e1ec5b70…`
2021-02-18 23:40 UTC · source 2021-02-18	`8fc7167e32ce…`	`e96bbc724034…`
2020-12-18 03:04 UTC · source 2020-12-17	`4184dd79f89f…`	`545327b3e20f…`
2020-06-10 20:45 UTC · source 2020-06-10	`4bd3596a7b87…`	`5c64c6f6865f…`
2019-12-08 06:16 UTC · source 2019-12-05	`263afe128892…`	`91768de4ddbe…`
2019-06-01 22:24 UTC · source 2019-05-30	`5b2001dcd8f5…`	`54b53d4dc9e4…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A072062-001	LOXAPINE SUCCINATE	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB		1988-06-15

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A072062-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A072062-001	LOXAPINE SUCCINATE	EQ 50MG BASE	CAPSULE / ORAL	AB	1988-06-15	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A072062-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A072062-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A072062-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A072062-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A072062-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A072062-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A072062-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A072062-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A072062-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A072062-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A072062-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A072062-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A072062-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A072062-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A072062-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A072062-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A072062-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A072062-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A072062-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A072062-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A072062-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A072062-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A072062-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A072062-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A072062-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A072062-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A072062-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A072062-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A072062-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A072062-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A072062-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A072062-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A072062-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A072062-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A072062-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A072062-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A072062-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A072062-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A072062-001	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A072062-001	AB	1	`cb3db0bc1861…`

Additional Listing Data#

Finished product: Yes
Brand name base: Loxapine
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
LOXAPINE SUCCINATE	50 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
X59SG0MRYU	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
311385	Internal RxNorm lookup
311386	Internal RxNorm lookup
314075	Internal RxNorm lookup
314078	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
a6107bb1-3e23-4c5d-bbf4-5e29deff6728	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
777d68c6-a5ab-e06c-d314-677b0b9af0c8	Product name	2	20240508
d1b2bd99-c28a-46e0-9dad-cfbb5a5ed33e	Product name	1	20201015

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0591-0372-01	Loxapine	100 in 1 BOTTLE, PLASTIC	CAPSULE	100		20

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0591-0372-01	EA - Each	0591-0372	752536fc-18b8-44ae-a962-d46827f029db	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
LOXAPINE SUCCINATE	ACTIVE INGREDIENT	X59SG0MRYU	LOXAPINE CAPSULE [WATSON LABORATORIES, INC.]	13
LOXAPINE	ACTIVE MOIETY	LER583670J	LOXAPINE CAPSULE [WATSON LABORATORIES, INC.]	13
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	LOXAPINE CAPSULE [WATSON LABORATORIES, INC.]	13
BENZYL ALCOHOL	INACTIVE INGREDIENT	LKG8494WBH	LOXAPINE CAPSULE [WATSON LABORATORIES, INC.]	13
BUTYLPARABEN	INACTIVE INGREDIENT	3QPI1U3FV8	LOXAPINE CAPSULE [WATSON LABORATORIES, INC.]	13
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	LOXAPINE CAPSULE [WATSON LABORATORIES, INC.]	13
EDETATE CALCIUM DISODIUM	INACTIVE INGREDIENT	25IH6R4SGF	LOXAPINE CAPSULE [WATSON LABORATORIES, INC.]	13
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	LOXAPINE CAPSULE [WATSON LABORATORIES, INC.]	13
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	LOXAPINE CAPSULE [WATSON LABORATORIES, INC.]	13
GELATIN	INACTIVE INGREDIENT	2G86QN327L	LOXAPINE CAPSULE [WATSON LABORATORIES, INC.]	13
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LOXAPINE CAPSULE [WATSON LABORATORIES, INC.]	13
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	LOXAPINE CAPSULE [WATSON LABORATORIES, INC.]	13
POLACRILIN POTASSIUM	INACTIVE INGREDIENT	0BZ5A00FQU	LOXAPINE CAPSULE [WATSON LABORATORIES, INC.]	13
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	LOXAPINE CAPSULE [WATSON LABORATORIES, INC.]	13
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	LOXAPINE CAPSULE [WATSON LABORATORIES, INC.]	13
SODIUM PROPIONATE	INACTIVE INGREDIENT	DK6Y9P42IN	LOXAPINE CAPSULE [WATSON LABORATORIES, INC.]	13
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	LOXAPINE CAPSULE [WATSON LABORATORIES, INC.]	13
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LOXAPINE CAPSULE [WATSON LABORATORIES, INC.]	13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0591-0372	LOXAPINE CAPSULE [ACTAVIS PHARMA, INC.]	19	Current NDC, Legacy NDC, 1 package rows	20250326_a6107bb1-3e23-4c5d-bbf4-5e29deff6728.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Loxapine	LOXAPINE	REMEDYREPACK INC.	ae8e299c-4003-4ccf-badc-fb665a997b20	2026-07-14	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 072062 application number: ANDA072062
Loxapine	LOXAPINE	Actavis Pharma, Inc.	a6107bb1-3e23-4c5d-bbf4-5e29deff6728	2025-03-31	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 072062 application number: ANDA072062 ndc (product): 0591-0372

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
X59SG0MRYU	LOXAPINE SUCCINATE	27833-64-3	LOXAPINE SUCCINATE
LER583670J	LOXAPINE	1977-10-2	Loxapine

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
314078	loxapine succinate 10 MG Oral Capsule	PSN	a6107bb1-3e23-4c5d-bbf4-5e29deff6728	20
311385	loxapine succinate 25 MG Oral Capsule	PSN	a6107bb1-3e23-4c5d-bbf4-5e29deff6728	20
311386	loxapine succinate 5 MG Oral Capsule	PSN	a6107bb1-3e23-4c5d-bbf4-5e29deff6728	20
314075	loxapine succinate 50 MG Oral Capsule	PSN	a6107bb1-3e23-4c5d-bbf4-5e29deff6728	20
314078	loxapine 10 MG Oral Capsule	SCD	a6107bb1-3e23-4c5d-bbf4-5e29deff6728	20
311385	loxapine 25 MG Oral Capsule	SCD	a6107bb1-3e23-4c5d-bbf4-5e29deff6728	20
311386	loxapine 5 MG Oral Capsule	SCD	a6107bb1-3e23-4c5d-bbf4-5e29deff6728	20
314075	loxapine 50 MG Oral Capsule	SCD	a6107bb1-3e23-4c5d-bbf4-5e29deff6728	20
314078	loxapine 10 MG (as loxapine succinate 13.6 MG) Oral Capsule	SY	a6107bb1-3e23-4c5d-bbf4-5e29deff6728	20
311385	loxapine 25 MG (as loxapine succinate 34 MG) Oral Capsule	SY	a6107bb1-3e23-4c5d-bbf4-5e29deff6728	20
311386	loxapine 5 MG (as loxapine succinate 6.8 MG) Oral Capsule	SY	a6107bb1-3e23-4c5d-bbf4-5e29deff6728	20
314075	loxapine 50 MG (as loxapine succinate 68.1 MG) Oral Capsule	SY	a6107bb1-3e23-4c5d-bbf4-5e29deff6728	20
314075	loxapine succinate 50 MG Oral Capsule	PSN	ae8e299c-4003-4ccf-badc-fb665a997b20	18
314075	loxapine 50 MG Oral Capsule	SCD	ae8e299c-4003-4ccf-badc-fb665a997b20	18
314075	loxapine 50 MG (as loxapine succinate 68.1 MG) Oral Capsule	SY	ae8e299c-4003-4ccf-badc-fb665a997b20	18

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Status
0591-0372-00	00591037200	19800 CAPSULE in 1 BAG (0591-0372-00)	19800 capsule	15-JUN-88	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Loxapine capsules A072062 A072204 A072205 A072206	REMEDYREPACK INC.	2026-07-14	HUMAN PRESCRIPTION DRUG LABEL	20
Loxapine capsules A072062 A072204 A072205 A072206	Actavis Pharma, Inc.	2025-03-31	HUMAN PRESCRIPTION DRUG LABEL	20